Find Research Projects

Search results

• Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in

  Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.

  Project: Clinical Trial

• Phase 3, Randomized, Open-Label Study to Compare Ociperlimab (BGB-A1217) Plus Tislelizumab (BGB-A317) Plus Concurrent Chemoradiotherapy (cCRT) Followed by Ociperlimab Plus Tislelizumab or Tislelizumab Plus cCRT Followed by Tislelizumab Versus cCRT Followed by Durvalumab in Previously Untreated, Locally Advanced, Unresectable Non-Small Cell Lung Cancer

  Bernicker, E. H., Singh, M. & Zhang, J.

  Project: Clinical Trial

• Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of AL001 in FTD (AL001-3) (INFRONT-3)

  Masdeu, J. C., Faridar, A. & Pascual, B.

  10/20/20 → …

  Project: Clinical Trial

• Phase 3_Sotatercept_ Pulmonary Arterial Hypertension _Acceleron A011-12 SOTERIA A Long-term Follow-up Study of Sotatercept for PAH Treatment

  Safdar, Z. & Sahay, S.

  8/5/21 → …

  Project: Clinical Trial

• Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects With Previously Treated c-Met+ Non-Small Cell Lung Cancer

  Bernicker, E. H., Heyne, K., Singh, M. & Zhang, J.

  3/24/20 → …

  Project: Clinical Trial

• Pharmacokinetic Studies on Antidepressants Before and After Gastric Bypass Surgery

  Sherman, V.

  Texas Southern University

  7/1/13 → 6/30/14

  Project: Non Profit

• Pharmacokinetic Analysis of Once-Daily Everolimus and Extended-Release Tacrolimus in Renal Transplant Recipients (CRAD001AUS214T) (PO#3004249477)

  Gaber, A. O., Hobeika, M. J., Knight, R. J., Saharia, A. & Yi, S.

  10/17/19 → …

  Project: Clinical Trial

• PET Imaging for Breast Cancer

  University of Houston

  2/1/11 → 12/31/19

  Project: Non Profit

• PETCT for Vascular Graft Infection

  Rahimi, M., Al-Mallah, M., Le, L., Lumsden, A. B. & Peden, E. K.

  1/28/20 → …

  Project: Clinical Trial

• PERIGON Pivotal Trial

  Reardon, M. J., Kleiman, N. & Little, S. H.

  12/4/14 → …

  Project: Clinical Trial

• Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NRG-GY009)

  Kamat, A. A., Alaniz, A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.

  Project: Clinical Trial

• PBR28 PET

  Masdeu, J. C., Appel, S. H., Faridar, A., Karmonik, C., Nakawah, M. O. & Pascual, B.

  6/7/16 → …

  Project: Clinical Trial

• Patricia Levy Zusman International Workshop on Neuroregeneration (Zusman Workshop)

  Horner, P. J.

  12/15/22 → 12/14/23

  Project: Federal Funding Agencies

• Patient-Specific In Vitro Modeling Pertaining to CoreValve: Multi Modality Assessment of Paravalvular Regurgitation to Annular Calcification and Left Ventricular Outflow Tract Geometry

  Little, S. H.

  American Heart Association

  1/1/14 → 12/31/15

  Project: Non Profit

• Pathological flow-induced endothelial damage and plaque erosion

  Cooke, J. P. & Le, N.

  7/15/19 → 6/30/23

  Project: Federal Funding Agencies

• Pathogenesis of Multiple Organ Failure-Project 3

  Univ of Texas Hlth Sci Ctr Houston

  8/1/06 → 5/31/09

  Project: Federal Funding Agencies

• Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)

  Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.

  8/23/21 → …

  Project: Clinical Trial

• PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2

  Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A. & Singh, M.

  Project: Clinical Trial

• P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy

  Lu, Y.

  2/1/22 → 5/31/25

  Project: Federal Funding Agencies

• Oxidized mitochondrial DNA employs APEX1 in neutrophils to control lupus

  Zhang, Z. & Xing, J.

  1/1/17 → 2/14/20

  Project: Non Profit

• Oxidized amyloid proteins induce genome damage in Alzheimerâ??s disease

  Hegde, M.

  Alzheimer's Association

  3/1/14 → 9/30/15

  Project: Non Profit

• OX40L-OX40 costimulation in obesity-induced adipose inflammation

  1/1/17 → 6/1/19

  Project: Non Profit

• Outcome Registry on use of the Wingscan Stent System for Sumptomatic Intracranial Atherosclerosis

  Emory University

  3/1/06 → 9/30/06

  Project: Federal Funding Agencies

• Outcome-Driven Approach to Minimize the Risks of Facial Distortion Following CMF Surgery

  Gateno, J.

  8/1/20 → 7/31/25

  Project: Federal Funding Agencies

• Optogenetic integration of grafted neural stem cells

  Horner, P. J.

  7/31/17 → 7/30/20

  Project: Non Profit

• Optimizing Antibiotic Use in Treatment of Overactive Bladder: Evaluating the Need for Prophylactic Antibiotics Prior to OnabotulinumtoxinA Injection in Patients Without Urinary Tract Infection

  Kobashi, K. C., Gonzalez, R. & Khavari, R.

  Project: Clinical Trial

• Optimization of Opioid Discharge Prescriptions Following Thyroid and Parathyroid Surgeries

  Fink, E. & Gaber, A. O.

  1/1/20 → 8/31/22

  Project: Federal Funding Agencies

• Optimal Selective Thyroid Hormone Analogs for Metabolic Syndrome

  9/30/10 → 8/31/13

  Project: Federal Funding Agencies

• Open Label Study of Pitolisant (Wakix) as Adjunct Therapy for Subjects with Refractory Restless Legs Syndrome

  Ondo, W. G. & Waln, O.

  9/15/22 → …

  Project: Clinical Trial

• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 (JUNIPER)

  Abraham, B. P. & Glassner, K.

  Project: Clinical Trial

• Open Label and Placebo-Controlled Assessment of Sublingual Apomorphine (Kynmobi) as Adjunct Therapy for Subjects with Refractory Restless Legs Syndrome

  Ondo, W. G. & Waln, O.

  Project: Clinical Trial

• Open Label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR BCMA T Cells (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)

  Ganguly, S., Petkova, J., Pingali, S. R. & Shah, S.

  7/14/22 → …

  Project: Clinical Trial

• Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso (BREEZE)

  Sahay, S. & Safdar, Z.

  Project: Clinical Trial

• OCS Lung TOP Registry

  Suarez, E. E., Gaber, A. O., Goodarzi, A. & Huang, H. J.

  2/19/19 → …

  Project: Clinical Trial

• OCS Liver PROTECT CAP Trial

  Saharia, A., Hobeika, M. J., Mobley, C. M. & Victor, III, D. W.

  Project: Clinical Trial

• OCS Liver Perfusion (OLP) Post-Approval Registry Protocol

  Hobeika, M. J. & Mobley, C. M.

  Project: Clinical Trial

• Ocrelizumab for Psychosis by Autoimmunity (OPA)

  Masdeu, J. C., Faridar, A., Nakawah, M. O., Pascual, B., Toledo, J. B. & Weinstein, B.

  2/20/20 → …

  Project: Clinical Trial

• NY-ESO-1-specific TCR-Engineered T cell Immunotherapy for Triple Negative Breast Cancer

  Chang, J. C.

  9/30/16 → 9/29/23

  Project: Federal Funding Agencies

• NY-ESO-1-specific TCR-engineered T cell immunotherapy for triple negative breast cancer

  Wang, R. & Chang, J. C.

  9/30/16 → 10/28/19

  Project: Federal Funding Agencies

• NWBT 020221 - DC-Vax

  Baskin, D. S., Bernicker, E. H. & Powell, S. Z.

  Project: Clinical Trial

• NSABP B-51 A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary

  12/9/16 → 12/9/41

  Project: Non Profit

• NSABP B47-A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer

  Niravath, P. A., Chang, J. C. & Singh, M.

  Project: Clinical Trial

• NSABP43; NSABP47; ECOG 2108

  Chang, J. C.

  "NSABP Foundation, Inc"

  3/1/11 → 3/25/26

  Project: Non Profit

• NRG-LU005

  Zhang, J., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Farach, A. M., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A. & Singh, M.

  Project: Clinical Trial

• NRG-GY018. Also PRO00022968

  Zaid, T., Alaniz, A., Singh, M. & Suri, A.

  Project: Clinical Trial

• NRG-BR004: A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

  Geyer, C. E., Chang, J. C., Darcourt, J. & Niravath, P. A.

  3/12/19 → 2/28/25

  Project: Non Profit

• Novel therapy targeting refractory colon cancer

  Pan, P.

  9/25/15 → 8/31/23

  Project: Federal Funding Agencies

• Novel Therapy for Patients with Advanced Prostate Cancer Using Codependent Tumor-Specific T-Cells Expressing IL7 and IL7R

  Baylor College of Medicine

  9/30/11 → 9/29/12

  Project: Federal Funding Agencies

• Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells

  6/1/20 → 5/31/22

  Project: Federal Funding Agencies

• Novel Therapeutic Strategies to Co-Target AR+ and AR-/lo Prostate Cancer Cells

  6/1/19 → 5/31/24

  Project: Federal Funding Agencies